目录肽产品
AMYD-006B
Tamra-β-Amyloid (1-42)
Tamra-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
Tamra-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
Size：1.0
P1(RMB)：3065
MW：4926.6
One letter sequence：Tamra-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Molecular Formula：C228H331N57O64S1
Description：42-residue peptide believed to be the major subunit of the vascular and plaque filaments in individuals with Alzheimer's disease, elderly people and patients with Trisomy 21 (Down's Syndrome). Inactive control.
Literature Reference：Neurobiology of Aging, 13, No.5 (1992)
Cas：
P1(RMB)：3065
MW：4926.6
One letter sequence：Tamra-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Molecular Formula：C228H331N57O64S1
Description：42-residue peptide believed to be the major subunit of the vascular and plaque filaments in individuals with Alzheimer's disease, elderly people and patients with Trisomy 21 (Down's Syndrome). Inactive control.
Literature Reference：Neurobiology of Aging, 13, No.5 (1992)
Cas：
